Evidence map›Paper›PMID 9826739›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1998

Rat heart: a site of oxytocin production and action.

M Jankowski, F Hajjar, S A Kawas, S Mukaddam-Daher, G Hoffman, S M McCann, J Gutkowska

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03001635 (The Impact of Oxytocin Administration on Short and Long Term Prognosis in Patients Undergoing ST Elevation Myocardial Infarction), which is not on this map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
5.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03001635 phase2 / phase3unknown statusnot on this mapstarted 2017, after this paper: background citation

The Impact of Oxytocin Administration on Short and Long Term Prognosis in Patients Undergoing ST Elevation Myocardial Infarction

TypeinterventionalSponsorSheba Medical CenterRan2017Enrolled52ConditionsMyocardial InfarctionArmsOxytocin, Placebos
3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 211 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Navigating Central Oxytocin Transport: Known Realms and Uncharted Territories.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Complementary Role of Oxytocin and Vasopressin in Cardiovascular Regulation.International journal of molecular sciences · 2021
    Review
  18. HJournal of clinical medicine · 2021
    Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

M JankowskiCentre de Recherche, Centre Hospitalier de l'Université de Montréal, Campus Hôtel-Dieu, Montreal, H2W 1T8 Canada.
F Hajjar
S A Kawas
S Mukaddam-Daher
G Hoffman
S M McCann
J Gutkowska
Centre Hospitalier de l’Université de Montréal · CAPennington Biomedical Research Center · USRoyal Victoria Hospital · CALouisiana State University · US

Funding

MECHANISM OF ACTION OF CYTOKINES ON BRAIN AND PITUITARYR37MH051853 · NIMH · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI MCCANN, SAMUEL M · 1995 to 2002
$870k
NIMH NIH HHS MH51853
6 · The paper itself

Abstract

We report here that the rat heart is a site of oxytocin (OT) synthesis and release. Oxytocin was detected in all four chambers of the heart. The highest OT concentration was in the right atrium (2128 +/- 114 pg/mg protein), which was 19-fold higher than in rat uterus but 3.3-fold lower than in the hypothalamus. OT concentrations were significantly greater in the right and left atria than in the corresponding ventricles. Furthermore, OT was released into the effluent of isolated, perfused rat heart (34.5 +/- 4.7 pg/min) and into the medium of cultured atrial myocytes. Reverse-phase HPLC purification of the heart extracts and heart perfusates revealed a main peak identical with the retention time of synthetic OT. Southern blots of reverse transcription-PCR products from rat heart revealed gene expression of specific OT mRNA. OT immunostaining likewise was found in atrial myocytes and fibroblasts, and the intensity of positive stains from OT receptors paralleled the atrial natriuretic peptide stores. Our findings suggest that heart OT is structurally identical, and therefore derived from, the same gene as the OT that is primarily found in the hypothalamus. Thus, the heart synthesizes and processes a biologically active form of OT. The presence of OT and OT receptor in all of the heart's chambers suggests an autocrine and/or paracrine role for the peptide. Our finding of abundant OT receptor in atrial myocytes supports our hypothesis that OT, directly and/or via atrial natriuretic peptide release, can regulate the force of cardiac contraction.

Indexed as

AnimalsAnimals, NewbornAtrial Natriuretic FactorCells, CulturedFemaleHeartImmunohistochemistryIn Vitro TechniquesMyocardiumOxytocinRadioimmunoassayRatsRats, Sprague-DawleyReceptors, OxytocinReverse Transcriptase Polymerase Chain ReactionRNA, MessengerAtrial Natriuretic FactorOxytocinReceptors, OxytocinRNA, Messenger

Identifiers

PMID9826739
PMCPMC24412
OpenAlexW2158935024

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.